Navidea Biopharmaceuticals, Inc. (NAVB) financial statements (2022 and earlier)

Company profile

Business Address 4995 BRADENTON AVENUE
DUBLIN, OH 43017
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,2312,6701,0473,4764,5931,5397,166
Cash and cash equivalents4,2312,6701,0473,4762,7951,5397,166
Short-term investments    1,798  
Inventory, net of allowances, customer advances and progress billings151170  (1)1,471653
Inventory151170  (1)1,471653
Prepaid expense     348 
Other undisclosed current assets1,0013,6881,8692,1209,2417,4684,758
Total current assets:5,3836,5282,9165,59613,83210,82612,577
Noncurrent Assets
Operating lease, right-of-use asset128250282
Property, plant and equipment120132301622371,2521,928
Intangible assets, net (including goodwill)786620385428458181186
Intangible assets, net (excluding goodwill)786620385428458181186
Other noncurrent assets2272275388351,445203274
Other undisclosed noncurrent assets    4,809  
Total noncurrent assets:1,2621,2301,2351,4266,9491,6352,387
TOTAL ASSETS:6,6457,7584,1517,02220,78112,46214,965
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,6571,9492,0512,0751,7908,4912,918
Accounts payable1,4211,1621,1124258557,1231,768
Accrued liabilities4132141319422277
Employee-related liabilities1,1957559251,637916946874
Debt4537455573162,35451,958333
Estimated litigation liability    2,888  
Disposal group, including discontinued operation    7  
Deferred revenue and credits 2,3151,044
Other undisclosed current liabilities2,1892,0211,2129881,0307,0981,888
Total current liabilities:5,3004,7153,8203,3798,06869,8626,184
Noncurrent Liabilities
Long-term debt and lease obligation20296512  9,64160,746
Long-term debt, excluding current maturities     9,64160,746
Operating lease, liability20296512
Liabilities, other than long-term debt70070070064776251,870
Deferred revenue and credits 26193
Deferred revenue700700700
Other liabilities   64775991,678
Other undisclosed noncurrent liabilities   1,168588  
Total noncurrent liabilities:7209961,2121,23366510,26662,616
Total liabilities:6,0205,7115,0324,6118,73380,12868,800
Stockholders' equity
Stockholders' equity attributable to parent, including:(107)1,316(1,612)1,74211,380(68,135)(54,305)
Preferred stock, shares subscribed but unissued, subscriptions receivable (10,300)     
Common stock221218210200162156156
Common stock, share subscribed but unissued, subscriptions receivable (4,975)     
Common stock, value, subscriptions 11    
Additional paid in capital370,460375,428345,848338,265331,129326,564326,086
Accumulated other comprehensive loss   (1)(2)  
Accumulated deficit(370,788)(359,057)(347,671)(336,723)(319,909)(394,855)(380,547)
Other undisclosed stockholders' equity attributable to parent00     
Stockholders' equity attributable to noncontrolling interest731731731668669469470
Total stockholders' equity:6252,047(881)2,41012,048(67,666)(53,836)
TOTAL LIABILITIES AND EQUITY:6,6457,7584,1517,02220,78112,46214,965

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues5329156581,1691,81021,97013,249
Revenue, net10918,83311,388
Sublease income  378
Cost of revenue (1)(7)(97)(4)(2,297)(1,755)
Cost of goods and services sold    (4)(2,297)(1,755)
Gross profit:5329146511,0731,80719,67311,495
Operating expenses(12,592)(11,625)(11,614)(11,920)(15,684)(21,896)(30,045)
Operating loss:(12,060)(10,711)(10,963)(10,847)(13,877)(2,223)(18,551)
Nonoperating income (expense)(20)(11)181(33)(68)27
Investment income, nonoperating(6)1125  (40) 
Other nonoperating income (expense)(14)(22)(8)1(33)(28)27
Interest and debt expense366(6)(8)(5,292)(4,202)(1,956)(2,441)
Loss from continuing operations before equity method investments, income taxes:(11,715)(10,728)(10,953)(16,138)(18,112)(4,247)(20,964)
Loss from equity method investments     (15)(305)
Other undisclosed income (loss) from continuing operations before income taxes 68(31)322(10,047)(7,489)
Loss from continuing operations before income taxes:(11,715)(10,722)(10,945)(16,169)(17,790)(14,309)(28,758)
Income tax expense (benefit)(16) (1)104,062 436
Loss from continuing operations:(11,731)(10,722)(10,946)(16,159)(13,727)(14,309)(28,322)
Income (loss) from discontinued operations  (3)   759
Loss before gain (loss) on sale of properties:(11,731)(10,722)(10,948)(16,159)(13,727)(14,309)(27,564)
Other undisclosed net income   4588,673  
Net income (loss):(11,731)(10,722)(10,948)(16,114)74,946(14,309)(27,564)
Net income attributable to noncontrolling interest0 00011
Other undisclosed net loss attributable to parent     (1) 
Net income (loss) attributable to parent:(11,731)(10,722)(10,948)(16,114)74,946(14,309)(27,563)
Preferred stock dividends and other adjustments (664)    (46)
Other undisclosed net income available to common stockholders, basic     1 
Net income (loss) available to common stockholders, diluted:(11,731)(11,386)(10,948)(16,114)74,946(14,308)(27,609)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(11,731)(10,722)(10,948)(16,114)74,946(14,309)(27,564)
Other undisclosed comprehensive income (loss)  12(2)  
Comprehensive income (loss):(11,731)(10,722)(10,947)(16,113)74,943(14,309)(27,564)
Comprehensive income, net of tax, attributable to noncontrolling interest0 00011
Comprehensive income (loss), net of tax, attributable to parent:(11,731)(10,722)(10,947)(16,112)74,944(14,308)(27,563)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: